Skip to main content
. 2020 Jun 1;53:e20200013. doi: 10.1590/0037-8682-0013-2020

TABLE 2: The symptoms of patients, treatments, etiological agents, and risk factors for patients described in articles published in 2005 and 2018.

Author Year Symptoms of Patients Treatment Etiological Agent Risk Factors
Hayashida et al. 45 2018 Erythematous nodules Amphotericin B and F. solani Acute myeloid leukemia
voriconazole
Simon et al. 46 2018 Pain and decreased vision Amphotericin B and voriconazole F. dimerum Acute myeloid leukemia
Boral at al. 47 2018 Blurred vision Voriconazole F. solani Ocular trauma
Combalia et al. 48 2018 Lesions on the Complete excision of F. solani Diabetes mellitus
eyebrow the lesions Kidney transplant
Immunosuppress treatment
Okada et al. 49 2018 Lesions forming an Liposomal F. solani Neutropenia
ulcer amphotericin B Varicella zoster virus
Puapatanakul et al. 50 2018 Peritonitis and septicemia Amphotericin B Fusarium spp. Diabetes mellitus Hypertension
End-stage kidney disease
Borges et al. 51 2018 Lesion Amphotericin B and F. solani Acute myeloid leukemia
itraconazole Neutropenia
Arnoni et al. 52 2018 Nodules on the chest Amphotericin B and voriconazole F. oxysporum Acute lymphocytic leukemia
Kumari et al. 53 2018 Lesions with pus discharge Itraconazole F. solani HIV positive
Yoshida et al. 54 2018 Blurred vision Amphotericin B and voriconazole F. solani Acute myeloid leukemia
Rizzello et al. 55 2018 Pain on eye Amphotericin B and voriconazole F. solani Acute lymphoblastic leukemia
Neutropenia
Anandi et al. 56 2005 Breast abscess Ketoconazole F. solani Diabetes mellitus
Gardner et al. 57 2005 Pruritic plaque on forearm Amphotericin B and voriconazole F. solani Neutropenia
Karam et al. 58 2005 Cutaneous nodules Voriconazole F. moniliforme Myeloblastic leukemia